Moderna Seeks Approval for Use of its COVID-19 Vaccine Among Kids Ages 12-17

Recently released data show that the Moderna COVID-19 vaccine is effective among children ages 12 to 17. Data were collected from a clinical trial of more than 3,700 adolescents. Among those who received two doses of the Moderna vaccine, no cases of COVID-19 were reported, which shows an efficacy rate of 100%. Moderna will seek Emergency Use Authorization to expand the vaccine’s reach to those ages 12 to 17. Currently, the Pfizer vaccine is the only COVID-19 immunization authorized for use in this age group. Click here to read more.